Collectively, these results suggested that PKC-α and Gal-3 overexpression are associated with increased cell apoptosis and collagen I synthesis in kidney, which qualify them as potential therapeutic targets in cisplatin-induced kidney injuries. The gene discussed is LGALS3; the disease is kidney injury.